Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 6/2009

01-11-2009 | Original Article

Conversion to sirolimus of patients with chronic allograft nephropathy—a retrospective analysis of outcome and influencing factors

Authors: Oliver Witzke, Ondrej Viklicky, Tobias R. Türk, Jens Lutz, Benjamin Wilde, Isabel Willenberg, Stefan Vitko, Uwe Heemann

Published in: Langenbeck's Archives of Surgery | Issue 6/2009

Login to get access

Abstract

Purpose

The purpose of this study was to analyse the outcome and its influencing factors in patients whose therapy was converted from calcineurin inhibitors (CNI) to sirolimus (SRL) due to chronic allograft nephropathy (CAN).

Materials and methods

Therapies of 78 patients (44 men) with CAN from three European transplant centres were converted from CNI therapy to SRL and followed 24 months. Slopes for creatinine clearance before and after conversion were calculated. Influencing factors were analysed by a multivariance analysis.

Results

The slope of the creatinine clearance improved significantly (−0.90 vs. −0.34 ml min−1 month−1; p < 0.01). In patients whose therapy was converted from cyclosporine A (CyA) to SRL, the slope improved significantly, whereas conversion from Tacrolimus (Tac) to SRL did not affect the slope. The benefit was more pronounced in (1) patients with low or moderate baseline creatinine clearance, (2) patients receiving SRL after conversion without additional mycophenolate mofetil and (3) patients with low or moderate proteinuria.

Conclusion

Conversion from CyA to SRL but not from Tac to CRL is associated with a reduced loss of renal allograft function in patients with CAN.
Literature
7.
go back to reference Stoves J, Newstead CG, Baczkowski AJ, Owens G, Paraoan M, Hammad AQ (2004) A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy. Nephrol Dial Transplant 19:2113–2120. doi:10.1093/ndt/gfh188 CrossRefPubMed Stoves J, Newstead CG, Baczkowski AJ, Owens G, Paraoan M, Hammad AQ (2004) A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy. Nephrol Dial Transplant 19:2113–2120. doi:10.​1093/​ndt/​gfh188 CrossRefPubMed
8.
go back to reference Francois H, Durrbach A, Amor M, Djeffal R, Kriaa F, Paradis V, Bedossa P, Charpentier B (2003) The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management. Nephrol Dial Transplant 18(9):1909–1916. doi:10.1093/ndt/gfg250 CrossRefPubMed Francois H, Durrbach A, Amor M, Djeffal R, Kriaa F, Paradis V, Bedossa P, Charpentier B (2003) The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management. Nephrol Dial Transplant 18(9):1909–1916. doi:10.​1093/​ndt/​gfg250 CrossRefPubMed
11.
go back to reference Flechner SM, Kobashigawa J, Klinthalm G (2008) Calcineurin inhibitor-sparing regimes in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22:1–15PubMed Flechner SM, Kobashigawa J, Klinthalm G (2008) Calcineurin inhibitor-sparing regimes in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22:1–15PubMed
12.
go back to reference Johnson RWG, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J (2001) Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72:777–786. doi:10.1097/00007890-200109150-00007 CrossRefPubMed Johnson RWG, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J (2001) Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72:777–786. doi:10.​1097/​00007890-200109150-00007 CrossRefPubMed
16.
go back to reference Diekmann F, Budde K, Oppenheimer F et al (2008) Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria. Transpl Int 21(2):152–155PubMed Diekmann F, Budde K, Oppenheimer F et al (2008) Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria. Transpl Int 21(2):152–155PubMed
17.
go back to reference Boratynska M, Banasik M, Watorek E, Falkiewicz K, Patrzalek D, Szyber P, Klinger M (2006) Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 38(1):101–104. doi:10.1016/j.transproceed.2005.12.023 CrossRefPubMed Boratynska M, Banasik M, Watorek E, Falkiewicz K, Patrzalek D, Szyber P, Klinger M (2006) Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 38(1):101–104. doi:10.​1016/​j.​transproceed.​2005.​12.​023 CrossRefPubMed
19.
go back to reference Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L (2005) Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20(11):2517–2523. doi:10.1093/ndt/gfh957 CrossRefPubMed Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L (2005) Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20(11):2517–2523. doi:10.​1093/​ndt/​gfh957 CrossRefPubMed
20.
go back to reference Ruiz JC, Diekmann F, Campistol JM, Sanchez-Fructuoso A, Rivera C, Oliver J, Fernandez-Fresnedo G, Arias M (2005) Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37(9):3833–3835. doi:10.1016/j.transproceed.2005.09.127 CrossRefPubMed Ruiz JC, Diekmann F, Campistol JM, Sanchez-Fructuoso A, Rivera C, Oliver J, Fernandez-Fresnedo G, Arias M (2005) Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37(9):3833–3835. doi:10.​1016/​j.​transproceed.​2005.​09.​127 CrossRefPubMed
21.
go back to reference Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G (2005) Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 16(12):3755–3762. doi:10.1681/ASN.2005060635 CrossRefPubMed Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G (2005) Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 16(12):3755–3762. doi:10.​1681/​ASN.​2005060635 CrossRefPubMed
22.
go back to reference Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF, Rapamune Maintenance Regimen Trial (2004) Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15(3):809–817. doi:10.1097/01.ASN.0000113248.59077.76 CrossRefPubMed Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF, Rapamune Maintenance Regimen Trial (2004) Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15(3):809–817. doi:10.​1097/​01.​ASN.​0000113248.​59077.​76 CrossRefPubMed
23.
Metadata
Title
Conversion to sirolimus of patients with chronic allograft nephropathy—a retrospective analysis of outcome and influencing factors
Authors
Oliver Witzke
Ondrej Viklicky
Tobias R. Türk
Jens Lutz
Benjamin Wilde
Isabel Willenberg
Stefan Vitko
Uwe Heemann
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 6/2009
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-008-0435-y

Other articles of this Issue 6/2009

Langenbeck's Archives of Surgery 6/2009 Go to the issue